Definitive Healthcare Cor...

NASDAQ: DH · Real-Time Price · USD
3.88
0.08 (2.11%)
At close: Aug 15, 2025, 9:56 AM

Definitive Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
60.75M 59.19M 62.29M 62.7M 63.74M 63.48M 65.93M 65.33M 60.96M 59.2M 60.6M 57.38M 54.55M 50.12M 46.31M 43.08M 39.82M 36.94M
Cost of Revenue
14.14M 15.43M 14.69M 13.67M 22.69M 22.42M 22.45M 11.89M 11.17M 11.91M 9.79M 9.72M 11.78M 11.33M 10.9M 10.48M 9.87M 9.44M
Gross Profit
46.61M 43.76M 47.6M 49.03M 41.05M 41.06M 43.48M 56.66M 49.79M 47.3M 50.8M 47.66M 42.77M 38.8M 35.41M 32.6M 29.95M 27.5M
Operating Income
-4.17M -184.79M -99.56M -225.37M -3.15M -7.71M -8.26M -295.38M -12.07M -12.94M -7.3M -958K -11.21M -9.78M -12.17M -4.03M -6.62M -2.16M
Interest Income
1.75M 2.05M 3.21M 3.74M 3.72M 3.93M 3.77M 3.46M 3.57M 2.83M n/a 608K n/a n/a n/a n/a n/a n/a
Pretax Income
-8.81M -165.98M -90.61M -201.55M -328.09M -13.5M -12.19M -266.22M -13.09M -16.31M -10.31M -6.37M -9.79M -12.97M -14.09M -20.97M -15.04M -10.49M
Net Income
-7.55M -107.23M -59.08M -130.9M -213.63M -9.52M -10.23M -171.53M -8.57M -15.6M 6.74M -6.35M -5.15M -13.06M -9.7M -15.79M -15.04M -10.49M
Selling & General & Admin
33.14M 32.92M 28.88M 31.48M 34.07M 38.64M 40.17M 37.35M 38.37M 37.06M 38.74M 34.9M 32.98M 31.75M 29.02M 22.26M 19.26M 16.38M
Research & Development
7.97M 9.3M 8.98M 7.28M 10.12M 10.13M 11.57M 10.76M 10.23M 9.88M 10.13M 9.21M 8.71M 6.85M 5.75M 4.75M 4.28M 3.79M
Other Expenses
n/a 186.32M 109.31M 235.63M n/a n/a n/a 303.93M -797K 9.59M 10.04M 10.04M 4M 9.87M 9.87M 9.76M -100K 124K
Operating Expenses
41.11M 228.55M 147.16M 274.4M 44.19M 48.77M 51.74M 352.04M 58.29M 56.54M 58.91M 54.14M 51.88M 48.47M 44.63M 36.76M 33.14M 29.62M
Interest Expense
2.99M 2.43M 3.51M 3.75M 3.76M 3.82M 3.9M 3.9M 3.79M 3.61M 1.48M 3.07M 2.58M 1.88M 1.92M 7.19M 8.32M 8.45M
Selling & Marketing Expenses
20.47M 20.65M 20.37M 20.13M 21.55M 21.76M 23.61M 22.8M 24.7M 23.42M 23.52M 21.18M 23.59M 21.29M 17.38M 14.38M 12.88M 11.74M
Cost & Expenses
64.25M 243.98M 161.85M 288.06M 433.38M 79.73M 76.01M 360.7M 69.46M 68.44M 68.7M 63.87M 63.66M 59.8M 55.53M 47.25M 43.01M 39.06M
Income Tax Expense
456K -10.89M -5.89M -13.72M -21.9M -780K 1.18M -17.53M -1.48M -710K -17.04M -15K -213K 87K 675K n/a n/a n/a
Shares Outstanding (Basic)
106.82M 112.78M 115.02M 116.38M 117.75M 117.43M 116.42M 114.53M 111.77M 108.23M 105.08M 102.9M 99.2M 97.16M 92.55M 88.26M 87.53M 87.52M
Shares Outstanding (Diluted)
106.82M 112.78M 115.02M 116.38M 117.75M 117.43M 116.42M 114.53M 111.77M 108.23M 102.01M 102.9M 99.2M 97.16M 92.55M 88.26M 87.53M 87.52M
EPS (Basic)
-0.07 -0.95 -0.51 -1.12 -1.81 -0.08 -0.09 -1.5 -0.08 -0.14 0.06 -0.06 -0.05 -0.13 -0.1 -0.18 -0.17 -0.12
EPS (Diluted)
-0.07 -0.95 -0.51 -1.12 -1.81 -0.08 -0.09 -1.5 -0.08 -0.14 0.04 -0.06 -0.05 -0.13 -0.1 -0.18 -0.17 -0.12
EBITDA
8.52M -149.73M -73.97M -184.74M -311.54M 3M 4.71M -249.3M 3.48M -124K 3.86M 9.29M 8.56M 4.17M 3.06M 1.34M 11.71M 12.57M
EBIT
-5.82M -163.55M -87.1M -197.8M -324.32M -9.68M -8.29M -262.32M -9.3M -13.07M -8.83M -3.83M -7.59M -11.51M -12.17M -13.78M -3.19M -2.12M
Depreciation & Amortization
14.34M 13.82M 13.13M 13.06M 12.79M 12.68M 13M 13.03M 12.78M 12.94M 12.69M 13.19M 15.77M 15.25M 15.24M 15.12M 14.91M 14.69M